Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...
Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity but without diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback